Jamere Jackson
Jamere Jackson's purchase track record
Jamere Jackson has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/10/2025 | AZO | $188K | +8.5% | -9.1% | +5.5% |
| 8/8/2025 | LLY | $128K | +48.1% | +69.8% | +8.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Eli Lilly gets EMA backing for Foundayo obesity pill. The European Medicines Agency panel issued a positive opinion on Lilly's Foundayo pill for obesity and type 2 diabetes, clearing a regulatory hurdle for the drug. Recent coverage also notes Lilly's broader pipeline beyond Zepbound and rising competitive pressure on Novo Nordisk. In parallel, the company's largest shareholder announced a $347 million stock sale, adding another layer of market interest.
Transaction History
| AZO | ▲ Buy | Grant | 1 | $3K | 3/31/2026 | View on chart |
| AZO | ▲ Buy | Grant | 2 | $7K | 12/31/2025 | View on chart |
| AZO | ▲ Buy | Open Market | 55 | $188K | 12/10/2025 | View on chart |
| LLY | ▲ Buy | Grant | 215 | $220K | 11/17/2025 | View on chart |
| AZO | ▲ Buy | Grant | 2 | $9K | 9/30/2025 | View on chart |
| LLY | ▲ Buy | Open Market | 200 | $128K | 8/8/2025 | View on chart |
| AZO | ▲ Buy | Grant | 2 | $7K | 6/30/2025 | View on chart |
| AZO | ▼ Sell | Open Market | 350 | $1.3M | 5/30/2025 | View on chart |
| AZO | ▼ Sell | Open Market | 1,378 | $5.1M | 5/30/2025 | View on chart |
| AZO | ▼ Sell | Open Market | 232 | $864K | 5/30/2025 | View on chart |
| AZO | ▲ Buy | Option Exercise | 2,962 | $3.3M | 5/30/2025 | View on chart |
| AZO | ▼ Sell | Open Market | 2 | $7K | 5/30/2025 | View on chart |
| AZO | ▼ Sell | Open Market | 80 | $299K | 5/30/2025 | View on chart |
| AZO | ▼ Sell | Open Market | 80 | $298K | 5/30/2025 | View on chart |
| AZO | ▼ Sell | Open Market | 131 | $489K | 5/30/2025 | View on chart |
| AZO | ▼ Sell | Open Market | 178 | $664K | 5/30/2025 | View on chart |
| AZO | ▼ Sell | Open Market | 181 | $675K | 5/30/2025 | View on chart |
| AZO | ▲ Buy | Grant | 1 | $4K | 3/31/2025 | View on chart |
| AZO | ▲ Buy | Grant | 2 | $6K | 12/31/2024 | View on chart |
| LLY | ▲ Buy | Grant | 303 | $220K | 11/18/2024 | View on chart |
| AZO | ▲ Buy | Grant | 2 | $6K | 9/30/2024 | View on chart |
| AZO | ▲ Buy | Grant | 3 | $9K | 6/30/2024 | View on chart |
| AZO | ▲ Buy | Grant | 1 | $0 | 6/30/2024 | View on chart |
| AZO | ▲ Buy | Grant | 2 | $6K | 3/31/2024 | View on chart |
| AZO | ▲ Buy | Grant | 13 | $34K | 12/31/2023 | View on chart |
| AZO | ▲ Buy | Grant | 2 | $0 | 12/31/2023 | View on chart |
| LLY | ▲ Buy | Grant | 335 | $200K | 11/20/2023 | View on chart |
| AZO | ▲ Buy | Grant | 1 | $3K | 9/30/2023 | View on chart |
| AZO | ▲ Buy | Grant | 1 | $2K | 6/30/2023 | View on chart |
| AZO | ▲ Buy | Grant | 2 | $5K | 3/31/2023 | View on chart |
| AZO | ▲ Buy | Grant | 1 | $2K | 12/31/2022 | View on chart |
| LLY | ▲ Buy | Grant | 498 | $180K | 11/21/2022 | View on chart |
| AZO | ▲ Buy | Grant | 2 | $4K | 9/30/2022 | View on chart |
| AZO | ▲ Buy | Grant | 1 | $2K | 6/30/2022 | View on chart |
| AZO | ▲ Buy | Grant | 2 | $4K | 3/31/2022 | View on chart |
| AZO | ▲ Buy | Grant | 1 | $2K | 12/31/2021 | View on chart |
| LLY | ▲ Buy | Grant | 677 | $175K | 11/15/2021 | View on chart |
| AZO | ▲ Buy | Grant | 2 | $3K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
AutoZone Shares Rise as Rep Sells $65K, Director Steps Down
AutoZone shares climbed while the broader market fell, helped by a recent sale of up to $65,000 by a member of the House of Representatives. The company also saw a notable change in leadership as Director Claire McDonough announced she will not seek reelection after taking a new executive role. Whale activity in the sector added to the trading volume, and analysts continue to view the stock as a long‑term holding for some investors.
AutoZone Shares Rise as Rep Sells $65K, Director Steps Down. AutoZone shares climbed while the broader market fell, helped by a recent sale of up to $65,000 by a member of the House of Representatives. The company also saw a notable change in leadership as Director Claire McDonough announced she will not seek reelection after taking a new executive role. Whale activity in the sector added to the trading volume, and analysts continue to view the stock as a long‑term holding for some investors.